Early Use of Antiseizure Medication in Mechanically Ventilated Traumatic Brain Injury Cases: A Retrospective

Kelly D Haque1, Zachary M Grinspan2,3, Elizabeth Mauer2

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, NY Presbyterian Hospital-Weill Cornell Medicine, New York, NY.

Insights

In children with traumatic brain injury (TBI), early levetiracetam use was linked to fewer seizures compared to phenytoin. This study analyzed 3,479 pediatric TBI patients to compare antiseizure medication effectiveness.

Area of Science:

  • Pediatric Neurology
  • Neurocritical Care
  • Trauma Surgery

Background:

  • Traumatic brain injury (TBI) is a major cause of child mortality and morbidity.
  • Post-traumatic seizures affect 25% of severe pediatric TBI cases, potentially worsening outcomes.

Purpose of the Study:

  • To examine the association between early seizure occurrence and antiseizure medication choice in pediatric TBI.
  • To compare levetiracetam versus phenytoin for early seizure prevention in mechanically ventilated children with TBI.

Main Methods:

  • Retrospective cohort study of 3,479 children (<18 years) with TBI admitted to 51 U.S. children's hospitals (2010-2017).
  • Compared patients receiving levetiracetam on day 0 versus phenytoin on day 0.
  • Seizure occurrence identified via ICD-9/10-CM codes.

Main Results:

  • Levetiracetam was given to 67% and phenytoin to 33% of patients.
  • Seizures occurred in 37% of levetiracetam patients vs. 41% of phenytoin patients (p=0.02).
  • Multivariable analysis showed phenytoin use was associated with a 1.26-fold increased likelihood of seizures (aOR 1.26; 95% CI, 1.07-1.48; p=0.01).

Conclusions:

  • Early levetiracetam administration showed a lower incidence of seizures compared to early phenytoin in pediatric TBI.
  • Further research is needed to confirm causality and explore potential confounding factors or selection bias.
Abstract